GlaxoSmithKline – Management (2009)

Board of Directors

Roy Malcolm Anderson (1947-)
– Non-Executive Director since 2009.
– Chair of the science advisory board of WHO‘s Neglected Tropical Diseases programme.
– Member of the Bill and Melinda Gates Grand Challenges advisory board, and chair of the Schistosomiasis Control Initiative advisory board funded by the Gates Foundation.
– Temporary member of the Scientific Advisory Group for Emergencies, group set up to give scientific advice to the British government over health issues relating to swine flu.
– Rector of Imperial College (2008-2009).
– Fellow of the Royal Society (1986), the Academy of Medical Sciences, and the Royal Statistical Society (2004).
– Honorary Fellow of the Institute of Actuaries.
– Foreign Associate Member of the Institute of Medicine at the US National Academy of Sciences.
– Chair in Infectious Disease Epidemiology at the Department of Infectious Disease Epidemiology at Imperial College (2007).
– Chief Scientific Adviser to the UK Ministry of Defence (2004-2007).
– At numerous government and international agency committees advising on public health and disease control including the World Health Organisation and UNAIDS.
– Governor of the Wellcome Trust (1991-2000).
– Head of the Zoology department and Linacre Chair of Zoology; Director for the Epidemiology of Infectious Disease for the Wellcome Centre at the University of Oxford (1993-2000).
– Professor of Parasite Ecology (1982); head of the Department of Biology (1984-1993); Director of the Wellcome Centre for Parasite Infections (1989-1993) at Imperial College.
– Principal research interests in epidemiology, biomathematics, demography, parasitology, immunology, health economics, science policy and the public understanding of science.
– BSc degree in zoology and PhD degree in parasitology (1971) from Imperial College.
– Attended Duncombe School and Richard Hale School.
Knight of the British Empire (2006).
“The pandemic has started.” – Interview on the BBC’s Today programme (May, 2009)

Stephanie A. Burns (1955-)
– Non-Executive Director since 2009.
– Researcher working on water based and high temperature elastomers (1983); Director of Women’s Health (1994); Science and Technology Director for Europe (1997); Board of Directors (2000); President and Chief Executive Officer (2003); Chief Operating Officer (2004); Chairman (2006) at Dow Corning.
– Executive Committee of the Society of Chemical Industry.
– Board of Directors at the Society of Women’s Health Research, the American Chemical Society, The Conference Board, and Manpower (2003-2007).
– Served on the Michigan Molecular Institute.
– Post-doctoral studies at the Universite Montpellier, Sciences et Techniques du Languedoc, France.
– Ph.D. in organic chemistry, with an organosilicon specialty, from Iowa State University.

H. Lawrence Culp, Jr. (1964-)
– Non-Executive Director since 2009.
– President and Chief Executive Officer of Danaher Corporation.
– Positions in Accenture, previously Andersen Consulting.

Crispin Davis (1949-)
– Non-Executive Director since 2009.
– Chief Executive of Reed Elsevier plc (1999-2009).
– Chief Executive of Aegis Group plc (1994-1999).
– Member of the main board at Guinness plc and Group Managing Director of United Distillers (1992-1993).
– 20 years with Procter and Gamble.
Knight of the British Empire (2004), for services to the information industry.

Christopher Charles Gent (1948-)
– Chairman since January 2005; Non-Executive Deputy Chairman (2004).
– Non-executive director of Lehman Brothers Holdings Inc..
– Non-executive director of Ferrari SpA.
– Member of KPMG‘s Chairman Advisory Group.
– Senior Adviser at Bain & Co.
– Advisory Board of Reform.
– Member of the Board (1985-1997), Chief Executive Officer since January 1997 and Chief Executive Officer of Vodafone Group Plc until July 2003.
– Chairman of the Supervisory Board of Mannesmann AG.
– Non-executive director of China Mobile Limited.
– Board of Verizon Wireless.
– Vice President of the Computer Services Association Council.
– Director of Network Services and responsible for computer bureau services worldwide at International Computers Ltd (Fujitsu Services Limited).
– Managing Director of Baric, computer services company owned jointly by Barclays and International Computers Ltd.
– National Chairman of the Young Conservatives (1977-1979).
– Computer services manager at Schroders.
– Management trainee for the National Westminster Bank (1971).
– Attended Tenison’s School.
Knight of the British Empire (2001), for services to the telecoms industry.

Andrew Witty
– CEO designate in October 2007; Chief Executive Officer since 2008; and member of the Board and Corporate Executive Team.
– Non-Executive Director of the UK’s Office for Strategic Co-ordination of Health Research.
Imperial College Commercialisation Advisory Board.
– Member of the Health Innovation Council.
– Member of INSEAD UK Council.
– Member of the Business Council for Britain.
– Board Member of PhRMA.
– Vice-President of EFPIA.
– Member of the Singapore Economic Development Board‘s International Advisory Council.
– Advisory roles to Governments around the world including South Africa, Singapore, Guangzhou China and the UK.
– Board Member of the Singapore Economic Development Board, the Singapore Land Authority and awarded the Public Service Medal by the Government of Singapore in 2003.
– Senior Vice President, Asia Pacific prior to his appointment to the Corporate Executive Team as President of GSK Europe (2003-2008).
– Worked in the Company’s International New Products groups, both in the Respiratory and HIV/Infectious disease fields and involved in multiple new product development programmes.
– Vice President and General Manager, Marketing for Glaxo Wellcome Inc., the group’s US subsidiary.
– Managing Director of Glaxo South Africa (1993) and later Area Director for Glaxo Wellcome, South and East Africa.
– Sales Representative for the Respiratory business, variety of Marketing roles and Director of Pharmacy and Distribution at Glaxo (1985).

Julian Heslop
– Chief Financial Officer since April 2005.
– Board member for the specialist HIV company formed by GSK & Pfizer.
– Senior Vice President Operations Controller, member of the pharmaceutical operating committee and chaired the capital review team at GSK (2001-2005).
– Financial Controller of Glaxo Wellcome (1998-2001).
– Senior roles in brewing, property and food businesses and latterly Group Controller at Grand Metropolitan (1986).
– Management accounting and strategic planning roles at Imperial Brewing and Leisure (1979).
– Auditor at Stoy Hayward (1978).
– Chartered accountant working for John M. Winter (1977).

Deryck C. Maughan (1947-)
– Non-Executive Director.
– Non-Executive Director of Thomson Reuters and BlackRock Inc.
– Chairman of US-Japan Business Council.
– Member of the Trilateral Commission.
– Trustee of Lincoln Center, NYU Medical Center, Carnegie Hall and the Japan Society.
– Advisory Council at Harvard University and Stanford University.
– Independent Non-Executive Director; Partner of Kohlberg Kravis Roberts and Co.; Chairman of Kohlberg Kravis Roberts Japan.
– £4m donation to King’s College to be put towards the College’s Maughan Library, which was subsequently named in his honour (2002).
– Vice Chairman of the New York Stock Exchange (1996-2000).
– Chairman and CEO of Citigroup International (1998-2004) and Salomon Smith Barney (1997-1998).
– Tokyo Branch Manager (1986-1988); Chairman Asia (1988-1991); COO (1991-1992); Chairman and CEO (1992-1997) at Salomon Brothers Inc. (Citigroup).
– Worked at Goldman Sachs.
– UK Official Economic Adviser, Her Majesty’s Treasury (1969-1979).
– BA from King’s College (1969), and MBA from Stanford Graduate School of Business where was a Harkness Fellow.
Knight of the British Empire (2002).

James Murdoch (1972-)
– Non-Executive Director.
– Leadership Council of The Climate Group.
– Chairman and Chief Executive of News Corporation, Europe and Asia.
– Non-Executive Chairman of British Sky Broadcasting and member of the Board of News Corporation.
– Trustee of Harvard Lampoon.
– Chief Executive Officer of British Sky Broadcasting (2003-2007).
– Formerly executive vice-president of News Corporation; controlling shareholder of British Sky Broadcasting; and board of directors of News Datacom.
– Chairman and Chief Executive Officer of Star TV, satellite television in Asia (2000).
– Financier of Rawkus Records (1995-1998).
– Chairman of Festival Records, News Corporation (1996).
– Member of Gore 2000 and Hillary Clinton for President.
– At Horace Mann School (1991) and Harvard University (dropped out 1995).
– Father: Rupert Murdoch, News Corporation.
– Wife: Kathryn Hufschmid, for the Clinton Climate Initiative.

Dr Daniel Podolsky
– Non-Executive Director.
– Board of the Southwest Medical Foundation.
– Chairman of the Board & Scientific Co-Founder of the GI Company.
– Director of Antibe Therapeutics Inc.
– President of the University of Texas Southwestern Medical Center in Dallas.
– Philip O’Bryan Montgomery Jr. M.D. Distinguished Presidential Chair in Academic Administration.
– Doris and Bryan Wildenthal Distinguished Chair in Medical Science.
– Chief Academic Officer of Partners HealthCare System.
– Formerly Mallinkrodt Professor of Medicine and Chief of Gastroenterology at Massachusetts General Hospital and Harvard Medical School.
– Past editor-in-chief of Gastroenterology.
– Past President of the American Gastroenterological Association.

Moncef Slaoui
– Chairman Research & Development and member of the Corporate Executive team since June 2006.
– Senior Vice President, Worldwide business development and external alliances, serving on the R&D Executive team.
– Member of Board of the Agency for Science, Technology & Research.
– In GSK Biologicals engineered the development of a robust vaccines pipeline, including Rotarix and Cervarix.
– Professor of immunology at the University of Mons, Belgium.
– PhD in Molecular Biology and Immunology from the Université Libre de Bruxelles, Belgium, and completed postdoctoral studies at Harvard Medical School and Tufts University School of Medicine, Boston.

Tom de Swaan
– Non-Executive Director since January 2006.
– Supervisory Board of VanLanschot Bankers.
– Board of Directors of Zurich Financial Services.
– Vice Chairman of the Supervisory Board and Chairman of the Audit Committee of Royal Ahold.
– Member of the Supervisory Board of Royal DSM.
– Non-Executive Director of the Financial Services Authority.
– Board of the Institute of International Finance.
– Managing Board and CFO of ABN AMRO, member of the governing board of the Dutch Central Bank and Chairman of the Basel Committee on banking supervision.

Robert Wilson
– Non-Executive Director.
– Non-Executive Chairman of BG Group plc.
– Executive Chairman of Rio Tinto plc.

Corporate Executive Team

Abbas Hussain
– President Emerging Markets since June 2009.
– Non-executive director of Aspen Pharmacare Holdings Limited.
– Board member of ViiV Healthcare.
– Sales Representative GP & Hospital Sales East London (1988); Associate of Market Research & New Product Planning and subsequently District Sales Manager in Austrlia (1990); Associate of Global Product Planning (Cardiovascular Business Unit) in Indianapolis (1994); Associate of Business Development Asia Pacific (1995); Pharmaceutical Sales & Marketing Director in India (1996); Managing Director of Turkey (1998); General Manager Lilly Deutschland and General Manager and Speaker Lilly Pharma Holding GmbH (2001); European Mid-Size Area Director (2003); Vice President of Europe with specific responsibility for the Western European Mid-Size countries, Africa & Middle East Area/Commonwealth of Independent States and Central & Eastern Europe regions; and President Europe for Eli Lilly and Company.
– Degree in Medicinal Chemistry & Pharmacology from Loughborough University of Technology, UK.

Simon Bicknell
– Senior Vice President, Company Secretary since 2000 and Compliance Officer since 2006.
– Responsible for risk management, compliance and strategic auditing and chairs the company’s Risk Oversight and Compliance Council.
– Company Secretariat (1984); Deputy Secretary of Glaxo Wellcome (1995); and Company Secretary of GlaxoSmithKline plc (2000).
– Member of MiddleTemple.

John Clarke
– President Consumer Healthcare since January 2006.
– President of the GSK Consumer Healthcare Futures Group.
– Joined Beecham in 1976; Marketing and General Manager roles in Australasia, South Africa, The Far East, Japan, Canada and the UK; General Manager of the nutritional healthcare business (1996); President Consumer Healthcare Europe (1998-2003); and President Futures Group (2004).
– Triple-major Bachelor of Commerce degree from Otago University, New Zealand.

Deirdre Connelly
– President North American Pharmaceuticals since February 2009.
– Member of the Board of Directors of Macy’s Inc., the US department store chain.
– President of US operations at Eli Lilly and Company (2005); positions of regional sales director, executive director of global marketing for Evista, an osteoporosis treatment for post-menopausal women (1997-2001); promoted to leader of the woman’s health business unit in the US affiliate; executive director of human resources for the US affiliate (2003); and policy committee (2004); senior vice president for Human Resources; General Manager for Eli Lilly Puerto Rico S.A. (1995); marketing associate (1984); sales representative (1983).
– Graduated from the Harvard University‘s Advanced Management Program in 2000.
– Bachelor’s degree in economics and marketing from Lycoming College in Pennsylvania in 1983.

Marc Dunoyer
– President Asia Pacific/Japan since May 2008.
– Senior Vice President and Regional Director Japan (1999); President Pharmaceuticals Japan (2003).
Hoechst Marion Roussel until 1999.
– MBA from the Hautes Etudes Commerciales and Bachelor of Law degree from Paris University.

Eddie Gray
– President Pharmaceuticals Europe since January 2008.
– Senior Vice President and General Manager, Pharmaceuticals UK (2001).
– Advisory board member of Opportunity Now.
– Director of the British Pharma Group.
– Positions of increasing responsibility (1988); Head of Hospital Sales, Marketing Manager for Anti-Infective products and Business Unit Director for the UK Pharmaceuticals General Medicine business; Market Research for the US Pharmaceuticals business; Vice President & Director of Anti-Infectives Marketing, then Vaccines Marketing in the US; Executive Management Team for North America; and Vice President & General Manager Canada of SmithKline Beecham Pharmaceuticals.
– Honours degree in Chemistry and Management Studies from the University of London, and an MBA from the Cranfield School of Management in the UK.

Duncan Learmouth
– Senior Vice President, Corporate Communications and Community Partnerships, and member of the Corporate Executive Team of GSK.
– Honours degree in Ch since July 2006.
– Board member of ViiV Healthcare.
– Honours degree in Ch.
– Vice President, Global Investor Relations and Competitive Excellence of GSK.
– Honours degree in Ch.
– Joined Glaxo Wellcome.
– Honours degree in Ch in 1991; Investor Relations department (1997); Vice President of Investor Relations (2000); Vice President, Global Investor Relations with responsibility for the global IR function (2001).
– Financial Investigations and Trading Arrangements departments, and Financial Controller of Adechsa S.A., based in Zug, Switzerland.
– Chartered Accountant (1991) at Deloitte and Touche (1988) in London.
– Degree in Chemistry at Durham University.

Bill Louv
– Senior Vice President, Information Technology and Chief Information Officer since January 2007.
– Vice President of Medical Data Sciences (1994); senior roles in R&D and IT, including Senior Vice President, Information Technology for US Pharmaceuticals business at Glaxo Inc.
– Positions of increasing responsibility at Marion Merrell Dow including Vice President of Global Statistics and Clinical Data Management.
– Associate professor of epidemiology and biostatistics at the University of Alabama Medical Center.
– Bachelor of Science degree in Biology from the College of William and Mary, and Master of Science and Doctor of Philosophy degrees in Statistics from the University of Florida.

Dan Phelan
– Chief of Staff with primary responsibility for leading the critical support functions since May 2008; Senior Vice President Human Resources (2001).
– Board of Directors of Tyco Electronics.
– Member of the Dean’s Advisory Council at Rutgers School of Law-Camden.
– Manager of Labour Relations (1981); Vice President Employee Relations (1986); Vice President Human Resources (1987); Vice President and Director Personnel-US, Pharmaceuticals (1989); Senior Vice President and Director, Operations and Administration, Research & Development in SmithKline Beecham.
– Internship with the National Labor Relations Board.
– Clerkship with the Chief Judge of the US Federal District Court in New Jersey.
– At the labour department of a major Philadelphia law firm.
– Director in the Office of Student Services at Ohio State.
– Officer in the US Army Medical Service Corps.
– Honours graduate of Rutgers University, New Jersey.

David Pulman
– President, Global Manufacturing and Supply since December 2002; Senior Vice President, Strategy, Logistics and North American Supply (2001).
– Joined Glaxo in 1978; Senior Vice President Europe supply (2000); member of the merger integration team, with responsibility for facilitating international commercial; North American Supply, GMS Global logistics and strategy, and team leading and monitoring the Global supply network programme.
– PhD in microbiology from Newcastle University.

David Redfern
– Chief Strategy Officer since May 2008.
– Senior Vice President, Northern Europe with responsibility for managing pharmaceutical businesses in Denmark, Finland, Iceland, Ireland, the Netherlands, Norway, Sweden and Switzerland.
– Corporate Accounts Manager (1994); Corporate Development team (1995-1999); Senior Vice President and Chief Financial Officer of Pharma Europe (1999); Senior Vice President & Area Director, Central Europe (2003).
– Portfolio of audit clients and corporate transactions at PricewaterhouseCoopers until 1994.
– Bachelor of Science degree from Bristol University in the UK and Chartered Accountant.

Jean Stéphenne
– President and General Manager of GlaxoSmithKline Biologicals, Global Vaccine Division headquartered in Belgium, since 1998; Vice President and General Manager (1991), then Senior Vice President and General Manager; Vice President of Human Vaccines Research and Development and Production (1988-1991); Vaccine Plant Director and R&D Director (1981-1991); Vaccine Production Director (1980); Head of Bacterial and Viral Vaccines production (1974).
– Member of the European Association of Vaccine Producers, the Management Committee of the Belgian Companies Federation, and member of the Board of several Belgian companies.
– Elected by the Vaccine Industry CEO’s to be their representative on the GAVI Alliance Board and Executive Committee, for a 3 year mandate (starting in June 2008).
– President of the Union of French Speaking Companies (1998-2000).
– Named Baron by King Albert II of the Belgians in 2000 in recognition of his leading contribution to R&D and industry in Belgium.
– Engineer in Chemistry and Bio-Industries degree from the University of Gembloux, Belgium, in 1972 and degree in Management from the University of Louvain, Belgium.

Claire Thomas
– Senior Vice President Human Resources; previously Senior Vice President, Human Resources, Pharmaceuticals International.
– Senior Manager, Human Resources, Sales and Marketing Group, UK Pharmaceuticals (1996); Director of Human Resources for UK Pharmaceuticals (1997); Senior Vice President, Human Resources, Pharmaceuticals Europe (2001); strategic role in the radical redesign and delivery of the New Operating Model within Pharma Europe (2003-2006).
– Positions including HR Supervisor Dagenham Assembly Plant, HR Supervisor Sales & Marketing UK and Central Europe, and OD Manager European Engineering at Ford Motor Company.
– Honoured as an Outstanding European Woman of Achievement in 2007.
– Bachelor of Science degree in Economics, Management and Industrial Relations from the University of Wales.

Dan Troy
– Senior Vice President & General Counsel since September 2008.
– Partner at the Washington law firm Sidley Austin LLP, where represented mainly pharmaceutical companies and trade associations on matters related to the US Food and Drug Administration and government regulations.
– Chief Counsel for the FDA, where served as a primary liaison to the White House and the US Department of Health and Human Services.
– Law clerk for the US Circuit Court of Appeals for the District of Columbia Circuit.
– Graduate from Cornell University’s School of Industrial and Labor Relations, and law degree from Columbia University School of Law, where was a member of the Law Review and Kent Scholar.

Bob Ingram
– Vice Chairman Pharmaceuticals; former CEO and Chairman.
– Chairman of OSI Pharmaceuticals Inc.
– Lead Director of VALEANT Pharmaceuticals International.
– Board of Directors of Allergan Inc., Cree Inc., Edwards Lifesciences Corporation, and Lowe’s Companies Inc.
– Boards for the James B. Hunt Jr. Institute for Educational Leadership and Policy, Project HOPE, Research Triangle Foundation of North Carolina, H. Lee Moffitt Cancer Center, National Board for Professional Teaching Standards, President’s Roundtable CEO Roundtable on Cancer.
– Chairman of GlaxoSmithKline Foundation.
– General partner of Hatteras Venture Partners.
– Asked by former US President George H.W. Bush to form and chair the CEO Roundtable on Cancer.
– Appointed by President George W. Bush to the National Institutes of Health, National Cancer Advisory Board (2006).
– Awarded the Martin Luther King Jr. Legacy Award for International Service (2004).

Former Members

Jean-Pierre Garnier
– Chief Executive Officer and Executive Member of the Board of Directors of GSK (2000-2008).
– Director and Member of International Strategy Committee of Renault S.A.
– Board member of the Stanford Advisory Council on Interdisciplinary Biosciences and the Weill Cornell Medical College.
– UK Prime Minister Gordon Brown’s International Business Advisory Council.
– Advisory board of the Global Strategic Equities Fund founded and sponsored by Dubai International Capital LLC.
– Chief Executive Officer of Pierre Fabre S.A. (pharmaceuticals and cosmetics) in 2008.
– Chairman of the Board of Directors of NormOxys Inc.
– Vice Chairman of Innovation Philadelphia Inc.
– Director of INSEAD.
– Advisory Board of Quaker BioVentures.
– Director, Chairman of Committee on Compensation & Executive Development, Member of Committee on Nominations & Governance and Member of Public Issues Review Committee of United Technologies Corp. (1997).
– President of North American pharmaceutical department (1990-1994); chairman of pharmaceuticals (1994-1995); and Chief Executive Officer and Executive Member of the Board of Directors of SmithKline Beecham (1995-2000).
– Various management (1975-1983) and Director US Pharmaceutical Division (1983-1990) at Schering-Plough.
Chevalier de la Légion d’Honneur (1997) and Officier de la Legion d’Honneur of France (2007).

Charles E. Dadswell
– Legal positions at Glaxo and Glaxo Wellcome and Vice President of U.S. Intellectual Property at GSK.
– General Counsel of BioDelivery Sciences International since January 2008.
– Hospital sale representative and hospital Pharmacist.

Tadataka Yamada
– Chairman of Research and Development for GlaxoSmithKline Inc. (2000-2006); Chairman of Research and Development (1999), Non Executive Director (1994) at SmithKline Beecham.
– Trustee at Rockefeller Brothers Fund and The Franklin Institute.
– Director at Mallinckrodt Inc.
– Director, Member of Nominating & Governance Committee, and Compliance Committee at Covidien Ltd.
– Director and Member of Audit Committee at HLTH Corporation since May 1998.
Knight Commander of the British Empire since September 2007.
– Senior Advisor at Frazier Healthcare Ventures since 2006.
– President of the Global Health Program of the Bill & Melinda Gates Foundation since June 2006.
– Researcher at U.S. Army Medical Research Institute of Infectious Diseases.
– Director at diaDexus Inc. and Bioadvance.
– Past President of the American Gastroenterological Association and the Association of American Physicians.
– Professor and Chief of the Gastroenterology Division at the University of Michigan Medical School’s Internal Medicine department.
– Chairman of the Department of Internal Medicine at the University of Michigan Medical School and physician-in-chief at the University of Michigan Medical Center (1990-1996).
– Fellow of the Imperial College of Medicine.
– Member of the Institute of Medicine of National Academy of Science in the U.S. and the Academy of Medical Sciences in the United Kingdom.
– Master of the American College of Physicians.
– Resident at UCLA School of Medicine.
– B.A. in history at Stanford University and M.D. at New York University School of Medicine.


Etiquetas: , , , ,

A %d blogueros les gusta esto: